TY - JOUR
T1 - An artificial intelligence-enabled pipeline for medical domain
T2 - Malaysian breast cancer survivorship cohort as a case study
AU - Ganggayah, Mogana Darshini
AU - Dhillon, Sarinder Kaur
AU - Islam, Tania
AU - Kalhor, Foad
AU - Chiang, Teh Chean
AU - Kalafi, Elham Yousef
AU - Taib, Nur Aishah
N1 - Funding Information:
This project was supported by University of Malaya? s Prototype Research Grant Scheme (PR001-2017A) to the corresponding authors. HIR Grant (UM.C/HIR/MOHE/06) from the Ministry of Higher Education, Malaysia funded the Malaysian Breast Cancer Survivorship Cohort (MyBCC) study.
Funding Information:
Funding: This project was supported by University of Malaya′s Prototype Research Grant Scheme (PR001-2017A) to the corresponding authors. HIR Grant (UM.C/HIR/MOHE/06) from the Ministry of Higher Education, Malaysia funded the Malaysian Breast Cancer Survivorship Cohort (MyBCC) study.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8
Y1 - 2021/8
N2 - Automated artificial intelligence (AI) systems enable the integration of different types of data from various sources for clinical decision-making. The aim of this study is to propose a pipeline to develop a fully automated clinician-friendly AI-enabled database platform for breast cancer survival prediction. A case study of breast cancer survival cohort from the University Malaya Medical Centre was used to develop and evaluate the pipeline. A relational database and a fully automated system were developed by integrating the database with analytical modules (machine learning, automated scoring for quality of life, and interactive visualization). The developed pipeline, iSurvive has helped in enhancing data management as well as to visualize important prognostic variables and survival rates. The embedded automated scoring module demonstrated quality of life of patients whereas the interactive visualizations could be used by clinicians to facilitate communication with patients. The pipeline proposed in this study is a one-stop center to manage data, to automate analytics using machine learning, to automate scoring and to produce explainable interactive visuals to enhance clinician-patient communication along the survivorship period to modify behaviours that relate to prognosis. The pipeline proposed can be modelled on any disease not limited to breast cancer.
AB - Automated artificial intelligence (AI) systems enable the integration of different types of data from various sources for clinical decision-making. The aim of this study is to propose a pipeline to develop a fully automated clinician-friendly AI-enabled database platform for breast cancer survival prediction. A case study of breast cancer survival cohort from the University Malaya Medical Centre was used to develop and evaluate the pipeline. A relational database and a fully automated system were developed by integrating the database with analytical modules (machine learning, automated scoring for quality of life, and interactive visualization). The developed pipeline, iSurvive has helped in enhancing data management as well as to visualize important prognostic variables and survival rates. The embedded automated scoring module demonstrated quality of life of patients whereas the interactive visualizations could be used by clinicians to facilitate communication with patients. The pipeline proposed in this study is a one-stop center to manage data, to automate analytics using machine learning, to automate scoring and to produce explainable interactive visuals to enhance clinician-patient communication along the survivorship period to modify behaviours that relate to prognosis. The pipeline proposed can be modelled on any disease not limited to breast cancer.
KW - Artificial intelligence
KW - Automated analysis
KW - Breast cancer
KW - Machine learning
KW - Medical domain
UR - https://www.scopus.com/pages/publications/85113297382
U2 - 10.3390/diagnostics11081492
DO - 10.3390/diagnostics11081492
M3 - Article
C2 - 34441426
AN - SCOPUS:85113297382
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 8
M1 - 1492
ER -